Inactive Instrument

Insiders Hansa Biopharma AB Nasdaq Stockholm

Equities

SE0002148817

Real-time Estimate Cboe Europe Other stock markets 14:34:41 15/05/2024 BST			5-day change	1st Jan Change
38.34 ^SEK	-76.52%		-5.78%	-38.73%

04-18	Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024
04-18	Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hansa Biopharma Hires New CFO	02-22	MT
Hansa Biopharma Nomination Committee Formed	12-13	CI
Sweden's Hansa Biopharma CFO to Depart in February 2024	11-27	MT
Hahansa Biopharma AB Announces Resignation of Donato Spota as Chief Financial Officer, Effective 28 February 2024	11-27	CI
Sweden’s Hansa Biopharma Appoints New Chief Scientific Officer	01/09/23	MT
Hitto Kaufmann Appointed Chief Scientific Officer of Hansa Biopharma, Effective 1 December 2023	01/09/23	CI
Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma	06/03/23	AQ
Hansa Biopharma Names Former Pfizer Exec as Chief Commercial Officer	03/03/23	MT
Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma	03/03/23	AQ
Hansa Biopharma AB Appoints Matthew Shaulis as Chief Commercial Officer and US President of Hansa Biopharma	03/03/23	CI
Hansa Biopharma Chief Scientific Officer to Step Down in 2024	30/01/23	MT
Hansa Biopharma Announces Planned Departure of Chief Scientific Officer Christian Kjellman	30/01/23	CI
Correction Hansa Biopharma Nomination Committee formed	29/12/22	AQ
Correction: Hansa Biopharma Nomination Committee formed	28/12/22	AQ
Hansa Biopharma Nomination Committee formed - December 23, 2022	23/12/22	AQ
Hansa Biopharma Nomination Committee formed	23/12/22	AQ
Hansa Biopharma AB Announces Formation of Nomination Committee	23/12/22	CI
Hansa Biopharma AB Appoints Peter Nicklin as A New Member of the Board of Director	30/06/22	CI
Hansa Biopharma AB's Current Chair Ulf Wiinberg Has Chosen to Not Stand for Re-Election	30/05/22	CI
Hansa Biopharma AB Announces Ulf Wiinberg Not to Stand for Re-Election as Director	30/05/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Hansa Biopharma AB Nasdaq Stockholm

Equities

SE0002148817

Insiders

Filters